Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Covalent Laboratories Private Limited provides pharmaceutical products
Covalent Laboratories Private Limited, is an unlisted private company incorporated on 13 September, 2002. It is classified as a private limited company and is located in Hyderabad., Telangana. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 6.00 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
31.53%
273.48%
488.99%
44.17%
-27.56%
17.92%
5.7
6.63
5.47
23.16
27.87
-0.13
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(7)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 196.2 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 80.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 63.0 cr
RBL Bank Limited
No. of Loans: 1
Total Amount : 60.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 50.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Narayana Reddy Mundla
Shareholder
|
00064392 | 22 years |
| Managing Director | Madireddy Narayana Reddy
Shareholder
|
00123201 | 22 years |
| Whole-time Director | Maddireddy Vijaykiran
Shareholder
|
01095484 | 22 years |
| Director | Prasanth Nandigala
Shareholder
|
01740471 | 22 years |
| Director | Mundla Maha Vishnu | 02470664 | 0 years |
| Director | Abhinav Reddy Nandigala | 10362886 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| EMMENNAR CHEM PRIVATE LIMITED |
Amalgamated
|
5.0 Cr | 2 | Telangana |
| SV'S REMEDIES LIMITED |
Amalgamated
|
12.2 Cr | 3 | Telangana |
| VIRCHOW BIOTECH PRIVATE LIMITED |
Active
|
17.0 Cr | 1 | Telangana |
| ANDHRA ORGANICS LIMITED |
Active
|
4.5 Cr | 3 | Telangana |
| VIRCHOW HEALTHCARE PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
| VIRCHOW LABORATORIES LIMITED |
Active
|
75.0 L | 3 | Telangana |
| VIRCHOW PETROCHEMICAL PRIVATE LIMITED |
Active
|
2.8 Cr | 3 | Telangana |
| IMEX ENGINEERING CO PVT LTD |
Active
|
39.6 L | 2 | Telangana |
| VIRCHOW DRUGS LIMITED |
Active
|
12.2 Cr | 2 | Telangana |
| CYCLIC LIFE SCIENCES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| SIRI DRUGS INDIA PRIVATE LIMITED |
Amalgamated
|
7.3 Cr | 2 | Andhra Pradesh |
| SARACA LABORATORIES LIMITED |
Active
|
8.0 Cr | 2 | Telangana |
| POKARNA ENGINEERED STONE LIMITED |
Active
|
4.2 Cr | 1 | Telangana |
| POKARNA LIMITED |
Active
|
6.2 Cr | 1 | Telangana |
| EMNAR PHARMA PRIVATE LIMITED |
Active
|
19.9 Cr | 1 | Telangana |
| SV REAL HOLDINGS PRIVATE LIMITED |
Active
|
3.4 Cr | 1 | Telangana |
| SYNAC PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
| ALITHIA PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
| AARNA & AKSHAJ INDUSTRIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| PISTA MOTOR RACEWAY LLP |
Active
|
1.0 L | 1 | Telangana |
| AZICO PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SV'S REMEDIES LIMITED | India | - | - |
The incorporation date of COVALENT LABORATORIES PRIVATE LIMITED is 13 September, 2002
The authorized share capital of COVALENT LABORATORIES PRIVATE LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of COVALENT LABORATORIES PRIVATE LIMITED is INR ₹ 6.0 Cr.
The registered address of COVALENT LABORATORIES PRIVATE LIMITED is D.NO.8-3-677/18,S.K.D.NAGAR YELLAREDDYGUDA HYDERABAD. Telangana - 500073
The CIN number of COVALENT LABORATORIES PRIVATE LIMITED is U24230TG2002PTC039606.
Expand
Delete
Collapse
See
details
